Acta Cardiologica 2013-10-01

Long-term conservative management of a giant cardiac fibroma.

Martial Massin, Abderrahmane Fazia Ould, Caroline Jacquemart, Nasroolla Damry

Index: Acta Cardiol. 68(5) , 513-5, (2013)

Full Text: HTML

Abstract

A giant cardiac fibroma was discovered during evaluation for a soft systolic murmur in an asymptomatic 2-week-old girl. Echocardiography and magnetic resonance imaging showed a large intraventricular solid mass developed at the expense of the left ventricular lateral wall. Tumour progression resulted in failure to thrive and ventricular arrhythmia between 2 and 18 months of age. At that time, complete resection seemed unfeasible and conservative management with heart failure and antiarrhythmic medications was chosen. All drugs were discontinued when the patient was 5 years old. Since that time, the mass is stable and the patient is strictly asymptomatic. Conservative strategy seems to be acceptable in selected cases but close follow-up is mandatory.


Related Compounds

Related Articles:

Multiple modes of ryanodine receptor 2 inhibition by flecainide.

2014-12-01

[Mol. Pharmacol. 86(6) , 696-706, (2014)]

Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity.

2015-08-01

[Drug Metab. Pharmacokinet. 30 , 257-62, (2015)]

A misguided 'pill in the pocket' approach with flecainide leading to cardiac arrest.

2012-01-01

[BMJ Case Rep. 2012 , doi:10.1136/bcr-2012-006868, (2012)]

A case of near-fatal flecainide overdose in a neonate successfully treated with sodium bicarbonate.

2013-04-01

[J. Emerg. Med. 44(4) , 781-3, (2013)]

Hypertonic sodium bicarbonate versus intravenous lipid emulsion in a rabbit model of intravenous flecainide toxicity: no difference, no sink.

2013-06-01

[Clin. Toxicol. (Phila.) 51(5) , 394-7, (2013)]

More Articles...